BNGO News and Press, Bionano Genomics Inc. From 01/20/21

SAN DIEGO, Jan. 20, 2021 (GLOBE NEWSWIRE) -- BIONANO GENOMICS, INC. (Nasdaq: BNGO), announced today the pricing of its previously announced underwritten public offering of 33,333,350 shares of its common stock at a price to the public of $6.00 per share. The gross proceeds to Bionano f...

Shares of Bionano Genomics (NASDAQ: BNGO) rose 8.4% during market hours on Tuesday, only to fall roughly 10% after the market closed. Investors bid up Bionano's stock price after the biotech said on Monday that its Saphyr optical genome mapping (OGM) system could detect stru...

Bionano Genomics (BNGO) plans to offer and sale shares in an underwritten public offering; underwriters granted a 30-day option to purchase up to an additional 15% of shares.Actual size, offer terms not yet disclosed.After posting a 8% gain in single-day trade on positive Saphyr system o...

In a head-to-head comparison against traditional cytogenomics methods, Saphyr identified all actionable variants, plus important variants missed, improving clinical stratification for patient treatment In a single assay with comprehensive detection of relevant variants, Saph...

COVID-19 Host Genome Structural Variant (SV) Consortium used Saphyr to identify SVs in severe COVID-19 patients that affect genes involved in immunity, airway mucous, and viral replication SVs found by several investigators point to a central role for disease severity o...

The Nasdaq Composite (NASDAQINDEX: ^IXIC) has been doing very well in recent months, rising to set dozens of new record closing highs. On Friday, Nasdaq investors decided it was time for a pause, as the benchmark fell about half a percent just before 3 p.m. EST. However, some in...

Shares of Bionano Genomics (NASDAQ: BNGO) continued their rally on Friday, following the conclusion of the biotech's Next-Generation Cytogenomics Symposium. As of 2:40 p.m. EST, Bionano's stock price was up more than 17%. The final day of Bionano's symposium focused on the a...

Gainers: ObsEva (OBSV) +56%, DBV Technologies (DBVT) +44%, Senseonics Holdings (SENS) +39%, Avinger (AVGR) +33%, Bionano Genomics (BNGO) +28%.Losers: Cardiff Oncology (CRDF) -20%, SOS (SOS) -18%, Lexicon Pharmaceuticals (LXRX) -11%,&...

Bionano Genomics gains ([[BNGO]] +25.4%) after announcing the results and experiences of users of its research use only Saphyr system for optical genome mapping ((OGM)).Featured in day two of Bionano’s five-day Cytogenomics Symposium, presentations by scientists and clinicians ...

Charah Solutions (CHRA) +105% on being awarded large-scale, 12-Year ash marketing contract.DBV Technologies (DBVT) +57% on FDA response regarding Viaskin Peanut application.ObsEva (OBSV) +43%.Atlantic Power (AT) +41% on being acquired by I Squared Capital.Senseonics Holdings (S...